AIxMed, Inc.
AIxMed provides a platform that digitizes 3D cytology samples using advanced imaging technology, enabling pathologists to obtain clinical insights in seconds. This solution addresses the inefficiencies of traditional sample analysis, significantly reducing the time required for diagnosis and improving workflow in pathology labs.
- Artificial Intelligence
- Healthcare Technology
- Software Only
Updated 4 days ago
Funding
Raised to date
$2.8MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- AIxMed provides a platform that digitizes 3D cytology samples using advanced imaging technology, enabling pathologists to obtain clinical insights in seconds. This solution addresses the inefficiencies of traditional sample analysis, significantly reducing the time required for diagnosis and improving workflow in pathology labs.